Research and experimental development services

Tender description

NHSBT are looking to appoint a suitable Qualified Person (QP) on a contract basis to work alongside its existing in-house QPs to support a very active and rapidly growing portfolio of Investigational Medicinal Product (IMP) manufacturing projects. NHSBT has developed the capability over at least 20 years to manufacture a range of Biotechnology, Gene Therapy, Cell Therapy and Tissue Engineered Medicinal Products for Phase I/II clinical Trials. Many of these are categorised as Advanced Therapy Medicinal Products (ATMP) in accordance with EU Regulations. IMP manufacture is focussed at NHSBT facilities in Bristol (two separate sites at Filton and Lower Langford), Birmingham and Liverpool holding appropriate MIA(IMP). NHSBT manufacture IMP for both internally sponsored Clinical Trials and under contract for academic and commercial clients. NHSBT are looking to appoint a suitable Qualified Person (QP) on a contract basis to work alongside its existing in-house QPs to support a very active and rapidly growing portfolio of Investigational Medicinal Product (IMP) manufacturing projects.